nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0426	0.0567	CbGbCtD
Nilutamide—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0426	0.0567	CbGbCtD
Nilutamide—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0421	0.0559	CbGbCtD
Nilutamide—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0396	0.0526	CbGbCtD
Nilutamide—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0358	0.0475	CbGbCtD
Nilutamide—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0358	0.0475	CbGbCtD
Nilutamide—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.035	0.0465	CbGbCtD
Nilutamide—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0329	0.0437	CbGbCtD
Nilutamide—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0329	0.0437	CbGbCtD
Nilutamide—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0323	0.0429	CbGbCtD
Nilutamide—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0323	0.0429	CbGbCtD
Nilutamide—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.031	0.0412	CbGbCtD
Nilutamide—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0309	0.041	CbGbCtD
Nilutamide—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.03	0.0398	CbGbCtD
Nilutamide—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0297	0.0395	CbGbCtD
Nilutamide—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0297	0.0395	CbGbCtD
Nilutamide—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0271	0.036	CbGbCtD
Nilutamide—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0271	0.036	CbGbCtD
Nilutamide—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.026	0.0345	CbGbCtD
Nilutamide—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0257	0.0341	CbGbCtD
Nilutamide—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0249	0.0331	CbGbCtD
Nilutamide—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0225	0.0299	CbGbCtD
Nilutamide—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0225	0.0299	CbGbCtD
Nilutamide—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0216	0.0287	CbGbCtD
Nilutamide—AR—semen—acquired immunodeficiency syndrome	0.00577	0.185	CbGeAlD
Nilutamide—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00195	0.0624	CbGeAlD
Nilutamide—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.0017	0.0544	CbGeAlD
Nilutamide—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00151	0.0483	CbGeAlD
Nilutamide—POR—blood—acquired immunodeficiency syndrome	0.0013	0.0417	CbGeAlD
Nilutamide—POR—bone marrow—acquired immunodeficiency syndrome	0.00126	0.0404	CbGeAlD
Nilutamide—POR—spinal cord—acquired immunodeficiency syndrome	0.00126	0.0402	CbGeAlD
Nilutamide—POR—vagina—acquired immunodeficiency syndrome	0.00121	0.0387	CbGeAlD
Nilutamide—Enzalutamide—ALB—acquired immunodeficiency syndrome	0.00116	1	CrCbGaD
Nilutamide—POR—lung—acquired immunodeficiency syndrome	0.00114	0.0366	CbGeAlD
Nilutamide—AR—skin of body—acquired immunodeficiency syndrome	0.00101	0.0324	CbGeAlD
Nilutamide—AR—lymphoid tissue—acquired immunodeficiency syndrome	0.000819	0.0262	CbGeAlD
Nilutamide—POR—brain—acquired immunodeficiency syndrome	0.000809	0.0259	CbGeAlD
Nilutamide—AR—digestive system—acquired immunodeficiency syndrome	0.000809	0.0259	CbGeAlD
Nilutamide—POR—lymph node—acquired immunodeficiency syndrome	0.000782	0.025	CbGeAlD
Nilutamide—AR—blood—acquired immunodeficiency syndrome	0.00077	0.0247	CbGeAlD
Nilutamide—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000749	0.024	CbGeAlD
Nilutamide—AR—spinal cord—acquired immunodeficiency syndrome	0.000742	0.0238	CbGeAlD
Nilutamide—AR—vagina—acquired immunodeficiency syndrome	0.000714	0.0229	CbGeAlD
Nilutamide—CYP2C19—blood—acquired immunodeficiency syndrome	0.000714	0.0228	CbGeAlD
Nilutamide—AR—lung—acquired immunodeficiency syndrome	0.000675	0.0216	CbGeAlD
Nilutamide—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000662	0.0212	CbGeAlD
Nilutamide—AR—nervous system—acquired immunodeficiency syndrome	0.000625	0.02	CbGeAlD
Nilutamide—CYP2C8—blood—acquired immunodeficiency syndrome	0.000623	0.0199	CbGeAlD
Nilutamide—AR—central nervous system—acquired immunodeficiency syndrome	0.000602	0.0193	CbGeAlD
Nilutamide—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000581	0.0186	CbGeAlD
Nilutamide—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000578	0.0185	CbGeAlD
Nilutamide—CYP2C9—blood—acquired immunodeficiency syndrome	0.000553	0.0177	CbGeAlD
Nilutamide—AR—brain—acquired immunodeficiency syndrome	0.000478	0.0153	CbGeAlD
Nilutamide—AR—lymph node—acquired immunodeficiency syndrome	0.000462	0.0148	CbGeAlD
Nilutamide—CYP2C8—brain—acquired immunodeficiency syndrome	0.000387	0.0124	CbGeAlD
Nilutamide—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000284	0.00132	CcSEcCtD
Nilutamide—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.000284	0.00132	CcSEcCtD
Nilutamide—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.000284	0.00132	CcSEcCtD
Nilutamide—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000283	0.00132	CcSEcCtD
Nilutamide—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000282	0.00131	CcSEcCtD
Nilutamide—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000282	0.00131	CcSEcCtD
Nilutamide—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000281	0.00131	CcSEcCtD
Nilutamide—Anorexia—Indinavir—acquired immunodeficiency syndrome	0.000281	0.00131	CcSEcCtD
Nilutamide—Ill-defined disorder—Ritonavir—acquired immunodeficiency syndrome	0.00028	0.00131	CcSEcCtD
Nilutamide—Anaemia—Ritonavir—acquired immunodeficiency syndrome	0.000279	0.0013	CcSEcCtD
Nilutamide—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000279	0.0013	CcSEcCtD
Nilutamide—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000278	0.0013	CcSEcCtD
Nilutamide—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000276	0.00128	CcSEcCtD
Nilutamide—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000275	0.00128	CcSEcCtD
Nilutamide—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000274	0.00128	CcSEcCtD
Nilutamide—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000274	0.00128	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000274	0.00128	CcSEcCtD
Nilutamide—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000272	0.00127	CcSEcCtD
Nilutamide—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000272	0.00127	CcSEcCtD
Nilutamide—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000272	0.00127	CcSEcCtD
Nilutamide—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000271	0.00126	CcSEcCtD
Nilutamide—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000271	0.00126	CcSEcCtD
Nilutamide—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000271	0.00126	CcSEcCtD
Nilutamide—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000271	0.00126	CcSEcCtD
Nilutamide—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00126	CcSEcCtD
Nilutamide—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.00126	CcSEcCtD
Nilutamide—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000269	0.00125	CcSEcCtD
Nilutamide—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000269	0.00125	CcSEcCtD
Nilutamide—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.00125	CcSEcCtD
Nilutamide—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000268	0.00125	CcSEcCtD
Nilutamide—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000267	0.00125	CcSEcCtD
Nilutamide—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000267	0.00124	CcSEcCtD
Nilutamide—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000267	0.00124	CcSEcCtD
Nilutamide—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000267	0.00124	CcSEcCtD
Nilutamide—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000266	0.00124	CcSEcCtD
Nilutamide—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000266	0.00124	CcSEcCtD
Nilutamide—Rash—Didanosine—acquired immunodeficiency syndrome	0.000265	0.00123	CcSEcCtD
Nilutamide—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000265	0.00123	CcSEcCtD
Nilutamide—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000265	0.00123	CcSEcCtD
Nilutamide—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000264	0.00123	CcSEcCtD
Nilutamide—Headache—Didanosine—acquired immunodeficiency syndrome	0.000263	0.00123	CcSEcCtD
Nilutamide—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000263	0.00122	CcSEcCtD
Nilutamide—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000263	0.00122	CcSEcCtD
Nilutamide—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000262	0.00122	CcSEcCtD
Nilutamide—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000262	0.00122	CcSEcCtD
Nilutamide—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000262	0.00122	CcSEcCtD
Nilutamide—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000261	0.00122	CcSEcCtD
Nilutamide—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000261	0.00121	CcSEcCtD
Nilutamide—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000261	0.00121	CcSEcCtD
Nilutamide—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.00121	CcSEcCtD
Nilutamide—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.00026	0.00121	CcSEcCtD
Nilutamide—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000259	0.00121	CcSEcCtD
Nilutamide—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000259	0.00121	CcSEcCtD
Nilutamide—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000259	0.0012	CcSEcCtD
Nilutamide—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000258	0.0012	CcSEcCtD
Nilutamide—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000258	0.0012	CcSEcCtD
Nilutamide—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000258	0.0012	CcSEcCtD
Nilutamide—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.0012	CcSEcCtD
Nilutamide—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.0012	CcSEcCtD
Nilutamide—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000256	0.00119	CcSEcCtD
Nilutamide—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000256	0.00119	CcSEcCtD
Nilutamide—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000256	0.00119	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000255	0.00119	CcSEcCtD
Nilutamide—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000254	0.00118	CcSEcCtD
Nilutamide—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000254	0.00118	CcSEcCtD
Nilutamide—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000254	0.00118	CcSEcCtD
Nilutamide—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000254	0.00118	CcSEcCtD
Nilutamide—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000252	0.00117	CcSEcCtD
Nilutamide—Pain—Indinavir—acquired immunodeficiency syndrome	0.000252	0.00117	CcSEcCtD
Nilutamide—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000252	0.00117	CcSEcCtD
Nilutamide—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.00117	CcSEcCtD
Nilutamide—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00117	CcSEcCtD
Nilutamide—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000251	0.00117	CcSEcCtD
Nilutamide—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000251	0.00117	CcSEcCtD
Nilutamide—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00025	0.00117	CcSEcCtD
Nilutamide—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00025	0.00117	CcSEcCtD
Nilutamide—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.00025	0.00117	CcSEcCtD
Nilutamide—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00025	0.00116	CcSEcCtD
Nilutamide—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00025	0.00116	CcSEcCtD
Nilutamide—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000249	0.00116	CcSEcCtD
Nilutamide—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000248	0.00116	CcSEcCtD
Nilutamide—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.00116	CcSEcCtD
Nilutamide—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.00115	CcSEcCtD
Nilutamide—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.00115	CcSEcCtD
Nilutamide—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000246	0.00115	CcSEcCtD
Nilutamide—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000245	0.00114	CcSEcCtD
Nilutamide—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000245	0.00114	CcSEcCtD
Nilutamide—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000244	0.00114	CcSEcCtD
Nilutamide—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000243	0.00113	CcSEcCtD
Nilutamide—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000243	0.00113	CcSEcCtD
Nilutamide—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000242	0.00113	CcSEcCtD
Nilutamide—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000242	0.00113	CcSEcCtD
Nilutamide—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000242	0.00113	CcSEcCtD
Nilutamide—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000242	0.00113	CcSEcCtD
Nilutamide—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000241	0.00112	CcSEcCtD
Nilutamide—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000241	0.00112	CcSEcCtD
Nilutamide—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000241	0.00112	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000241	0.00112	CcSEcCtD
Nilutamide—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00024	0.00112	CcSEcCtD
Nilutamide—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000239	0.00112	CcSEcCtD
Nilutamide—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.00111	CcSEcCtD
Nilutamide—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000238	0.00111	CcSEcCtD
Nilutamide—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000238	0.00111	CcSEcCtD
Nilutamide—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000238	0.00111	CcSEcCtD
Nilutamide—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000238	0.00111	CcSEcCtD
Nilutamide—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000238	0.00111	CcSEcCtD
Nilutamide—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000238	0.00111	CcSEcCtD
Nilutamide—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000237	0.00111	CcSEcCtD
Nilutamide—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000237	0.0011	CcSEcCtD
Nilutamide—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.0011	CcSEcCtD
Nilutamide—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000235	0.00109	CcSEcCtD
Nilutamide—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000235	0.00109	CcSEcCtD
Nilutamide—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000233	0.00109	CcSEcCtD
Nilutamide—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000233	0.00109	CcSEcCtD
Nilutamide—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000233	0.00109	CcSEcCtD
Nilutamide—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000233	0.00109	CcSEcCtD
Nilutamide—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000233	0.00108	CcSEcCtD
Nilutamide—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000232	0.00108	CcSEcCtD
Nilutamide—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.00108	CcSEcCtD
Nilutamide—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000231	0.00108	CcSEcCtD
Nilutamide—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000231	0.00107	CcSEcCtD
Nilutamide—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000231	0.00107	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00023	0.00107	CcSEcCtD
Nilutamide—Rash—Stavudine—acquired immunodeficiency syndrome	0.00023	0.00107	CcSEcCtD
Nilutamide—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.00023	0.00107	CcSEcCtD
Nilutamide—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.00023	0.00107	CcSEcCtD
Nilutamide—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.00107	CcSEcCtD
Nilutamide—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000229	0.00107	CcSEcCtD
Nilutamide—Headache—Stavudine—acquired immunodeficiency syndrome	0.000229	0.00106	CcSEcCtD
Nilutamide—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000229	0.00106	CcSEcCtD
Nilutamide—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.00106	CcSEcCtD
Nilutamide—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000228	0.00106	CcSEcCtD
Nilutamide—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000228	0.00106	CcSEcCtD
Nilutamide—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000228	0.00106	CcSEcCtD
Nilutamide—Rash—Abacavir—acquired immunodeficiency syndrome	0.000227	0.00106	CcSEcCtD
Nilutamide—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000226	0.00105	CcSEcCtD
Nilutamide—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000226	0.00105	CcSEcCtD
Nilutamide—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000226	0.00105	CcSEcCtD
Nilutamide—Headache—Abacavir—acquired immunodeficiency syndrome	0.000225	0.00105	CcSEcCtD
Nilutamide—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000224	0.00105	CcSEcCtD
Nilutamide—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000224	0.00104	CcSEcCtD
Nilutamide—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000223	0.00104	CcSEcCtD
Nilutamide—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000223	0.00104	CcSEcCtD
Nilutamide—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000221	0.00103	CcSEcCtD
Nilutamide—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.00103	CcSEcCtD
Nilutamide—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.00103	CcSEcCtD
Nilutamide—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00022	0.00102	CcSEcCtD
Nilutamide—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.00102	CcSEcCtD
Nilutamide—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000219	0.00102	CcSEcCtD
Nilutamide—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000218	0.00102	CcSEcCtD
Nilutamide—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000217	0.00101	CcSEcCtD
Nilutamide—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000217	0.00101	CcSEcCtD
Nilutamide—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000217	0.00101	CcSEcCtD
Nilutamide—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000217	0.00101	CcSEcCtD
Nilutamide—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000216	0.00101	CcSEcCtD
Nilutamide—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000215	0.001	CcSEcCtD
Nilutamide—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.000998	CcSEcCtD
Nilutamide—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000214	0.000994	CcSEcCtD
Nilutamide—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000992	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.000991	CcSEcCtD
Nilutamide—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000212	0.000986	CcSEcCtD
Nilutamide—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.000985	CcSEcCtD
Nilutamide—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.000982	CcSEcCtD
Nilutamide—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000211	0.000982	CcSEcCtD
Nilutamide—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000211	0.000982	CcSEcCtD
Nilutamide—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000211	0.000982	CcSEcCtD
Nilutamide—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00021	0.000977	CcSEcCtD
Nilutamide—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000209	0.000973	CcSEcCtD
Nilutamide—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000209	0.000972	CcSEcCtD
Nilutamide—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.000961	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.000954	CcSEcCtD
Nilutamide—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000205	0.000954	CcSEcCtD
Nilutamide—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000203	0.000947	CcSEcCtD
Nilutamide—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.000946	CcSEcCtD
Nilutamide—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.000945	CcSEcCtD
Nilutamide—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.000945	CcSEcCtD
Nilutamide—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.00094	CcSEcCtD
Nilutamide—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000202	0.00094	CcSEcCtD
Nilutamide—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000202	0.000939	CcSEcCtD
Nilutamide—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.000939	CcSEcCtD
Nilutamide—Rash—Zidovudine—acquired immunodeficiency syndrome	0.0002	0.000931	CcSEcCtD
Nilutamide—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.0002	0.000931	CcSEcCtD
Nilutamide—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.0002	0.00093	CcSEcCtD
Nilutamide—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000928	CcSEcCtD
Nilutamide—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000199	0.000925	CcSEcCtD
Nilutamide—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000197	0.000918	CcSEcCtD
Nilutamide—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.000917	CcSEcCtD
Nilutamide—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000911	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.00091	CcSEcCtD
Nilutamide—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000195	0.000908	CcSEcCtD
Nilutamide—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000908	CcSEcCtD
Nilutamide—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000908	CcSEcCtD
Nilutamide—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000904	CcSEcCtD
Nilutamide—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000902	CcSEcCtD
Nilutamide—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000902	CcSEcCtD
Nilutamide—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000891	CcSEcCtD
Nilutamide—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000191	0.000888	CcSEcCtD
Nilutamide—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.000879	CcSEcCtD
Nilutamide—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000188	0.000877	CcSEcCtD
Nilutamide—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.000874	CcSEcCtD
Nilutamide—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.000874	CcSEcCtD
Nilutamide—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000188	0.000873	CcSEcCtD
Nilutamide—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000869	CcSEcCtD
Nilutamide—Rash—Indinavir—acquired immunodeficiency syndrome	0.000186	0.000866	CcSEcCtD
Nilutamide—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000186	0.000865	CcSEcCtD
Nilutamide—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000862	CcSEcCtD
Nilutamide—Headache—Indinavir—acquired immunodeficiency syndrome	0.000185	0.000861	CcSEcCtD
Nilutamide—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.000858	CcSEcCtD
Nilutamide—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.00085	CcSEcCtD
Nilutamide—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000834	CcSEcCtD
Nilutamide—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000834	CcSEcCtD
Nilutamide—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.000825	CcSEcCtD
Nilutamide—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000824	CcSEcCtD
Nilutamide—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000821	CcSEcCtD
Nilutamide—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.000818	CcSEcCtD
Nilutamide—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.000818	CcSEcCtD
Nilutamide—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000175	0.000816	CcSEcCtD
Nilutamide—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000175	0.000813	CcSEcCtD
Nilutamide—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.000812	CcSEcCtD
Nilutamide—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000793	CcSEcCtD
Nilutamide—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.00079	CcSEcCtD
Nilutamide—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.000786	CcSEcCtD
Nilutamide—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.000783	CcSEcCtD
Nilutamide—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.000782	CcSEcCtD
Nilutamide—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000782	CcSEcCtD
Nilutamide—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.000778	CcSEcCtD
Nilutamide—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.000771	CcSEcCtD
Nilutamide—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000759	CcSEcCtD
Nilutamide—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000756	CcSEcCtD
Nilutamide—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000756	CcSEcCtD
Nilutamide—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000746	CcSEcCtD
Nilutamide—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000738	CcSEcCtD
Nilutamide—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000731	CcSEcCtD
Nilutamide—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.00073	CcSEcCtD
Nilutamide—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000724	CcSEcCtD
Nilutamide—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000723	CcSEcCtD
Nilutamide—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000721	CcSEcCtD
Nilutamide—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000719	CcSEcCtD
Nilutamide—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000703	CcSEcCtD
Nilutamide—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000697	CcSEcCtD
Nilutamide—Rash—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000697	CcSEcCtD
Nilutamide—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000696	CcSEcCtD
Nilutamide—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000692	CcSEcCtD
Nilutamide—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000682	CcSEcCtD
Nilutamide—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.00067	CcSEcCtD
Nilutamide—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000665	CcSEcCtD
Nilutamide—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000664	CcSEcCtD
Nilutamide—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000661	CcSEcCtD
Nilutamide—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000656	CcSEcCtD
Nilutamide—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000626	CcSEcCtD
